After a recent, highly public failure in regulatory oversight of genetically engineered crop development, a new coalition has formed to push the USDA to review the activities of agricultural biotechnology companies with a keener eye. Watch this video to find out what the issues are, and what this new development might mean for companies.
A new coalition may have the clout to force USDA's hand on ag biotech oversight.
About the Author
Sara began her career working for NGOs in the international development and disaster response fields. She had an epiphany one day, and thought she had invented the concept of sustainable investing. While initially disappointed that others had thought of this long ago, she was fortunate to be able to enter the humming field of Sustainable and Responsible Investment (SRI). With the exception of a few years as an environmental consultant, she has never looked back. Her first job in the SRI field was with a Washington, DC-based research firm, where she conducted social and environmental analysis of publicly traded companies. From there, Sara moved to Europe to work as a senior sustainability analyst for a large SRI fund management team with 8 billion Euros under management. Now back in Washington, DC, Sara is a freelance writer and analyst primarily covering sustainability issues for investors and consumers.
Sara holds a Bachelor of Arts degree from the University of Virginia in French and Spanish, and a Master of Arts degree from George Mason University in Economics. Sara grew up in Asia and Africa, and observed first hand the direct and indirect impact companies' activities have on people and the environment, both positive and negative. She believes that it is entirely possible for all stakeholders to benefit and profit from companies' ingenuity and innovation.
Follow @SMurphSmiles